Cargando…

SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer’s Disease-Like Pathology in OXYS Rats

Alzheimer’s disease (AD) is the most common type of dementia and is currently incurable, and mitogen-activated protein kinase (MAPK) p38 is implicated in the pathogenesis of AD. p38 MAPK inhibition is considered a promising strategy against AD, but there are no safe inhibitors capable of penetrating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muraleva, Natalia A., Stefanova, Natalia A., Kolosova, Nataliya G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463502/ https://www.ncbi.nlm.nih.gov/pubmed/32731533 http://dx.doi.org/10.3390/antiox9080676

Ejemplares similares

The mitochondria-targeted antioxidant SkQ1 but not N-acetylcysteine reverses aging-related biomarkers in rats
por: Kolosova, Nataliya G., et al.
Publicado: (2012)

Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study
por: Stefanova, Natalia A., et al.
Publicado: (2019)

Suppression of AMD-Like Pathology by Mitochondria-Targeted Antioxidant SkQ1 Is Associated with a Decrease in the Accumulation of Amyloid β and in mTOR Activity
por: Muraleva, Natalia A., et al.
Publicado: (2019)

Changes in Glial Support of the Hippocampus during the Development of an Alzheimer’s Disease-like Pathology and Their Correction by Mitochondria-Targeted Antioxidant SkQ1
por: Rudnitskaya, Ekaterina A., et al.
Publicado: (2022)

Association of cerebrovascular dysfunction with the development of Alzheimer’s disease-like pathology in OXYS rats
por: Stefanova, Natalia A., et al.
Publicado: (2018)

Therapeutic Action of the Mitochondria-Targeted Antioxidant SkQ1 on Retinopathy in OXYS Rats Linked with Improvement of VEGF and PEDF Gene Expression
por: Markovets, Anton M., et al.
Publicado: (2011)

Antioxidant SkQ1 delays sarcopenia-associated damage of mitochondrial ultrastructure
por: Vays, Valeriya B., et al.
Publicado: (2014)

Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis
por: Andreev-Andrievskiy, Alexander A., et al.
Publicado: (2016)

MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats
por: Muraleva, Natalia A., et al.
Publicado: (2021)

P38 MAPK Signaling in the Retina: Effects of Aging and Age-Related Macular Degeneration
por: Muraleva, Natalia A., et al.
Publicado: (2023)

Mitochondria-targeted antioxidant SkQ1 reduces age-related alterations in the ultrastructure of the lacrimal gland
por: Bakeeva, Lora E., et al.
Publicado: (2016)

Mitochondria-targeted antioxidant SkQ1 inhibits age-dependent involution of the thymus in normal and senescence-prone rats
por: Obukhova, Lidia A., et al.
Publicado: (2009)

Rapamycin suppresses brain aging in senescence-accelerated OXYS rats
por: Kolosova, Nataliya G., et al.
Publicado: (2013)

The Mitochondria-Targeted Antioxidant SkQ1 Downregulates Aryl Hydrocarbon Receptor-Dependent Genes in the Retina of OXYS Rats with AMD-Like Retinopathy
por: Perepechaeva, M. L., et al.
Publicado: (2014)

Mitochondria-targeted antioxidant SkQ1 inhibits leukotriene synthesis in human neutrophils
por: Sud’ina, Galina F., et al.
Publicado: (2022)

Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents
por: Anisimov, Vladimir N., et al.
Publicado: (2011)

Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats
por: Stefanova, Natalia A., et al.
Publicado: (2014)

An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology
por: Stefanova, Natalia A., et al.
Publicado: (2016)

The Analgesic Effect of the Mitochondria-Targeted Antioxidant SkQ1 in Pancreatic Inflammation
por: Weniger, Maximilian, et al.
Publicado: (2016)

SkQ1 treatment and food restriction — two ways to retard an aging program of organisms
por: Skulachev, Vladimir P.
Publicado: (2011)

Mitochondria-Targeted Antioxidant SkQ1 Prevents Anesthesia-Induced Dry Eye Syndrome
por: Zernii, Evgeni Yu., et al.
Publicado: (2017)

Therapeutic Effect of the Mitochondria-Targeted Antioxidant SkQ1 on the Culture Model of Multiple Sclerosis
por: Fetisova, Elena K., et al.
Publicado: (2019)

Treating Neurodegenerative Disease with Antioxidants: Efficacy of the Bioactive Phenol Resveratrol and Mitochondrial-Targeted MitoQ and SkQ
por: Shinn, Lindsey J., et al.
Publicado: (2021)

Delayed Formation of Neonatal Reflexes and of Locomotor Skills Is Associated with Poor Maternal Behavior in OXYS Rats Prone to Alzheimer’s Disease-like Pathology
por: Kozlova, Tatiana, et al.
Publicado: (2022)

Postnatal Maturation of the Blood–Brain Barrier in Senescence-Accelerated OXYS Rats, Which Are Prone to an Alzheimer’s Disease-like Pathology
por: Rudnitskaya, Ekaterina, et al.
Publicado: (2023)

The Rat Brain Transcriptome: From Infancy to Aging and Sporadic Alzheimer’s Disease-like Pathology
por: Stefanova, Natalia A., et al.
Publicado: (2023)

Improved health-span and lifespan in mtDNA mutator mice treated with the mitochondrially targeted antioxidant SkQ1
por: Shabalina, Irina G., et al.
Publicado: (2017)

Mitochondria-targeted antioxidant SkQ1 improves impaired dermal wound healing in old mice
por: Demyanenko, Ilya A., et al.
Publicado: (2015)

Mitochondria-Targeted Antioxidant SkQ1 Improves Dermal Wound Healing in Genetically Diabetic Mice
por: Demyanenko, Ilya A., et al.
Publicado: (2017)

Mitochondrial antioxidant SkQ1 decreases inflammation following hemorrhagic shock by protecting myocardial mitochondria
por: Jia, Bo, et al.
Publicado: (2022)

Mitochondrion-targeted antioxidant SkQ1 prevents rapid animal death caused by highly diverse shocks
por: Skulachev, V. P., et al.
Publicado: (2023)

Single-Nucleotide Polymorphisms (SNPs) Both Associated with Hypertension and Contributing to Accelerated-Senescence Traits in OXYS Rats
por: Devyatkin, Vasiliy A., et al.
Publicado: (2020)

Mitochondria-Targeted Antioxidant SkQ1 Prevents the Development of Experimental Colitis in Mice and Impairment of the Barrier Function of the Intestinal Epithelium
por: Fedorov, Artem V., et al.
Publicado: (2022)

Genetic Variability of the AcrAB-TolC Multidrug Efflux Pump Underlies SkQ1 Resistance in Gram-Negative Bacteria
por: Nazarov, P. A., et al.
Publicado: (2019)

SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model
por: Petrov, Anton, et al.
Publicado: (2016)

Mitochondria-Targeted Antioxidants SkQ1 and MitoTEMPO Failed to Exert a Long-Term Beneficial Effect in Murine Polymicrobial Sepsis
por: Rademann, Pia, et al.
Publicado: (2017)

Quantitative trait loci on chromosome 1 for cataract and AMD-like retinopathy in senescence-accelerated OXYS rats
por: Korbolina, Elena E., et al.
Publicado: (2012)

Mitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators
por: Dvoretskaya, Yuliya, et al.
Publicado: (2021)

The Role of SKQ1 (Visomitin) in Inflammation and Wound Healing of the Ocular Surface
por: Wei, Yi, et al.
Publicado: (2018)

Glia Not Neurons: Uncovering Brain Dysmaturation in a Rat Model of Alzheimer’s Disease
por: Rudnitskaya, Ekaterina A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dbk81aj6dp83ba5n20r5lk26fr